Tirzepatide is a groundbreaking treatment agent for individuals battling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) https://allenbplk643101.newbigblog.com/47380922/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist